Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | 0.052 | 0.1 |
mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.1 |
mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | 0.046 | 0.1 |
mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.2 |
mRNA | etoposide | GDSC1000 | pan-cancer | AAC | 0.052 | 0.2 |
mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.2 |
mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | -0.07 | 0.2 |
mRNA | HLI 373 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.2 |
mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | 0.041 | 0.2 |
mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | 0.078 | 0.2 |